Close
Close

Murine Anti-Idiotypic Antibody Discovery Service

Overview Service Applications Published Data Service Highlight FAQ

Creative Biolabs specializes in providing unparalleled murine anti-idiotypic antibody production services. Our immunology team successfully optimized an immunization protocol, significantly improving murine anti-idiotypic antibody generation. We now produce these anti-idiotypes for diverse biotechnology and pharmaceutical clients.

Overview of Murine Anti-Idiotypic Antibody

Anti-idiotypic antibodies (anti-ID Abs) are antibodies specifically generated against the antigenic determinants (idiotypes) found within the variable regions of other antibodies. These anti-ID Abs can structurally mimic the antigenic determinants of natural antigens. This mimicry, coupled with their inherent immunogenicity and reactogenicity, yet absence of other properties of the original antigen, confers advantages in the development of vaccines and immunological diagnostic tools, particularly for viral infectious diseases.

Murine models stand as a cornerstone in monoclonal antibody production, widely favored for their robust immune responses and genetic tractability. Different murine strains are judiciously selected to optimize the generation of specific anti-ID Abs, tailoring the immune challenge to the nuances of the antibody drug immunogen. The extensive use of mice in antibody immunization campaigns has also led to the availability of numerous reagents and established protocols, further streamlining the discovery process.

A kind of murine. (Creative Biolabs Original)

The inherent advantages of using murine hosts for anti-ID Ab generation include the relatively fast turnaround times from immunization to hybridoma generation, favorable cost-effectiveness compared to other species, and the inherent capacity to produce antibodies with exceptional specificity and high binding affinity, which are paramount for critical applications like PK and ADA assays.

Service at Creative Biolabs

Creative Biolabs offers a comprehensive murine anti-ID Ab discovery service, meticulously designed to meet the rigorous demands of biopharmaceutical research. Our service encompasses the entire workflow, from immunogen preparation and optimized murine immunization protocols to hybridoma generation, phage display, or single B-cell screening. We employ state-of-the-art screening technologies, including competitive ELISA, BLI, and SPR, to identify anti-IDs with desired binding characteristics (e.g, blocking or non-blocking). Our robust platform ensures the delivery of highly specific, functionally validated, and purified anti-ID Abs, alongside stable hybridoma cell lines for long-term supply, all tailored to your specific project requirements.

Please click here to see more custom Anti-Idiotypic Antibodies Production Services from Creative Biolabs to meet your specific requirements.

Applications of Murine Anti-Idiotypic Antibody

Pharmacokinetic (PK) Studies

These antibodies are essential for accurately quantifying the concentration of antibody drugs in biological samples over time. They enable the precise measurement of free, total, or drug-target complexed forms of the therapeutic agent, providing critical data for understanding drug absorption, distribution, metabolism, and excretion (ADME), ultimately guiding optimal dosing regimens.

Anti-Drug Antibody (ADA) Assays

In immunogenicity assessments, anti-ID Abs serve as crucial positive controls. They are vital for detecting and quantifying the immune response against the therapeutic drug. Neutralizing anti-idiotypes can further assess the functional impact of patient-derived ADAs, ensuring the accuracy and consistency of immunogenicity assays mandated by regulatory guidelines.

Biosimilar Development

For biosimilar programs, anti-ID Abs are indispensable for demonstrating comparability between the biosimilar and the reference product. They facilitate direct comparisons in PK profiles and immunogenicity assessments, supporting regulatory approval pathways.

Target Validation and Functional Studies

Beyond quantitative assays, anti-ID Abs can be employed in early-stage research for target validation or to mimic or block specific receptor interactions, offering insights into the therapeutic mechanism of action and supporting lead candidate characterization.

Published Data

Cumulative incidence rate of diabetes development.Fig.1 Anti-Id injection impact on diabetes incidence in NOD mice.1

The presence of autoantibodies targeting the smaller isoform of glutamate decarboxylase (GAD65Ab) is a hallmark of Type 1 diabetes (T1D). To investigate the protective potential of GAD65Ab-specific anti-Id in T1D, monoclonal anti-Id mAb was developed in mice, targeting human GAD65Ab. This antibody demonstrated specificity for b96.11's antigen-binding site, recognizing GAD65Ab in human sera. Injections of mAb into Non Obese Diabetic (NOD) mice reduced diabetes incidence and delayed onset, highlighting its protective role.

Service Highlight

Exceptional Specificity and Binding Affinity

We rigorously screen and characterize anti-IDs to ensure exquisite specificity for your antibody drug and high binding affinities, critical for accurate assay performance.

Rapid Delivery Timelines

Our optimized workflows and advanced screening platforms are designed to accelerate the discovery process, delivering high-quality anti-IDs within industry-leading turnaround times.

Cost-Competitive Solutions

We offer highly competitive pricing structures without compromising on the quality or performance of our custom anti-ID Abs, providing excellent value for your research budget.

Tailored Antibody Modifications

Should your project require specific antibody formats or labeling for downstream applications, we offer a range of modification options to ensure seamless integration into your experimental design.

Proven Success Rate

Leveraging over two decades of expertise, our highly experienced team boasts a consistently high success rate in generating challenging anti-ID Abs, even for complex therapeutic modalities.

Comprehensive Project Support

Beyond antibody delivery, we provide in-depth technical consultation and support throughout your project, ensuring optimal application and performance of the anti-IDs.

FAQ

  1. Q: What specific information about my antibody drug do you need to initiate the anti-ID Ab discovery project?

    A: To begin, we require detailed information about your antibody drug, including its species origin, isotype, variable region sequences if available, and target antigen. Understanding its intended application (e.g, PK, ADA) is also crucial, as it guides our immunization and screening strategies to develop the most suitable anti-ID Abs for your specific needs.

  2. Q: How do you ensure the specificity of the generated anti-ID Abs, especially preventing cross-reactivity with endogenous immunoglobulins?

    A: Specificity is paramount. We employ a multi-tiered screening approach, including competitive ELISAs, BLI, and SPR, against the antibody drug and relevant control antibodies (e.g, isotype controls, human IgG, other antibody drugs). Furthermore, we often incorporate depletion steps during purification to remove any antibodies that might bind non-specifically to endogenous host immunoglobulins, ensuring exquisite specificity to your target therapeutic.

  3. Q: Can you generate both blocking (Type I) and non-blocking (Type II) anti-ID Abs for my antibody drug?

    A: Absolutely. Our screening methodologies are specifically designed to differentiate and select for both blocking (Type I, which competes with the antigen for binding) and non-blocking (Type II, which binds outside the paratope) anti-ID Abs. We utilize competitive binding assays to identify and isolate clones with the desired functional characteristics for your PK and ADA assays.

  4. Q: How do you handle challenging antibody drugs, such as those with low immunogenicity or complex structures like bispecifics or ADCs?

    A: We leverage our extensive experience to tackle challenging projects. This includes optimizing immunization strategies, such as using specialized adjuvants, different murine strains, or alternative immunization routes to break tolerance. For complex modalities like bispecifics or ADCs, we design targeted immunization and screening approaches to ensure specificity to the unique idiotype of the therapeutic component, even in the presence of other moieties.

  5. Q: What are the typical purity levels of the anti-ID Abs you deliver?

    A: Our standard purification protocols aim for a purity level of >95% as determined by SDS-PAGE, ensuring minimal contamination and high-quality reagents suitable for sensitive analytical applications. We can also provide higher purity levels if specifically requested for highly demanding assays, subject to project discussion.

  6. Q: Can you assist with the subsequent scale-up production of the identified anti-ID Abs?

    A: Yes, absolutely. Once a successful anti-ID Ab clone is identified and validated, we offer comprehensive scale-up production services. Whether you require milligram or gram quantities, we can seamlessly transition from discovery to large-scale production, ensuring consistent batch-to-batch quality and reliable supply for your ongoing studies and clinical trials.


Creative Biolabs provides you with high-level murine anti-idiotypic antibody production service. We have first-class technology and rich experience to help you develop antibody drugs.

Reference

  1. Wang, Xin, et al. "Anti-idiotypic antibody specific to GAD65 autoantibody prevents type 1 diabetes in the NOD mouse." PloS one 7.2 (2012): e32515. Distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium.

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Related Sections
Online Inquiry
CONTACT US
USA:
Europe:
Germany:
Call us at:
USA:
UK:
Germany:
Fax:
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2026 Creative Biolabs. | Contact Us